Agressive short on Titan. TTNPOh, look! Another short on a pharma company!
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
TTNP trade ideas
Titan going nowhere but down. TTNPNot a titan in the pharmaceutical world by any measure, and just broke the floor. This is almost certain now that this one will go even lower. And why not? All it seems this one has been doing is dropping and dropping and dropping.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
TTNP 1D Close Up w/bars patterntest
$31.19 Gap Close
Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
TTNP 1W ContinuedTest
Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
TTNP LongDowntrend Wedge breakout
Price crossed SMA13,50
OBV>OBV34
WR buy signal near current price (my scripts: Williams %R two lines)
Entry 2.6
Stop 2.0
Target 7.5
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
$TTNP is gonna fall todayPupm&Dump trading strategy idea.
$TTNP is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $4,15;
stop-loss — $4.40;
take-profit — $3.60;
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
TITAN PHARMACEUTICAL INCNASDAQ:TTNP
Hi, friends!
It's been a long time, hasn't it? My investment fund management training is over. It's been very difficult, but it's over and I'm happy) There is still a lot of work ahead, of course. Nevertheless, I plan to get back to writing posts on this platform. For now, let's start with weekend posts so that many of you can read, analyze what I' ve written and make up your own minds.
Here we go!
Next week's candidate is penny stock. Many people underestimate cheap stocks, thinking they are difficult to trade and manipulated. Yes, it happens. But cheap stocks are a godsend for the beginner, and as I see it, there are a lot of beginners on this site.
Well, let's get started.
What's on the chart:
1. The price is down more than 60% since August. That's good for us.
2. On November 5th, the fall was stopped. On November 6th, the fall began to be bought back. What does this tell us? A big long player has appeared in the stock.
3. From November 19th till December 1st, there was an opposition between the long and short players. On November 20th, the long player tried to take the shorts' SLs. But it did not work, the stock was sold and driven into the short zone.
4. From December 1st through February 9th we were drawn into a parabolic curve. This tells us that the long player is accumulating positions for a further move upwards.
5. February 1st - a false breakout on high volume. Short's SLs are being taken off.
5. February 9 and 10 - a false breakout by two bars. But the paper does not fall, so ask yourself why? After all, after such a formation, the fall should have been necessary.
6. On February 12th - the paper is bought again.
7. You have to understand that the hike up may not happen soon, but it will definitely happen!
My strategy:
1. Entry on breakout of the resistance level. SL behind the breakout bar.
Your SL must be placed only on the parameters of your strategy! Your TP also!
TTNP Technical Analysis 🧙 Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
TTNP Chart Analysis 30 min ChartRight now the company have a bearish consolidation because is moving sideways under the SMA 200. I think it is in a 50/50 chance right now because the chart also have previous spikes reaching the resistance level. Will be better play support and resistance until the Stock Price take a direction.
***Remember***
This is only my Idea, don't buy or sell because of my idea. Do your own research in the company before deciding either buy or sell at your own risk.
Put a little boogie in it. Titan's turn.We have a nice confirmation followed by a significant amount of consolidation... I'd rather call it accumulation to be honest.
We have some money coming into the sector as a whole and it seems a good handful of these small Med-Tech companies are benefiting one by one, with these nice impulsive blasts.
I think we have come to a point where we will some strong movement upwards to fill the range. Its a small risk because if we move below the previous fractal movement we create a new supply zone and continue down.
Lets ride this Titan upwards and nearly double our investment. Be smart. Good luck.
Titan Pharma On Tuesday Watchlist $ttnpTrade alert for break above Point of Control (redline)
Earnings highlights
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases.
Q4 GAAP EPS of -$0.08 in-line.
Revenue of $1.22M (-1.6% Y/Y) beats by $0.29M.
Titan Pharma Bullish SetupTitan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.